Status:

RECRUITING

Adding Lidocaine to Custodiol Mixture

Lead Sponsor:

Fayoum University Hospital

Conditions:

CAD

Arrhythmia Ventricular

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The Bretschneider solution, also known as Custodiol, has been widely used in open-heart surgery requiring cardiopulmonary bypass (CPB) since its introduction in 1970. Custodiol is widely favored by ca...

Detailed Description

After Ethical Review Board of Fayoum University Hospital (FUH) approval and clinicaltrials.gov registration, all patients scheduled for isolated on-pump Coronary Artery Bypass Grafting (CABG) surgery ...

Eligibility Criteria

Inclusion

  • patients scheduled for elective Coronary artery bypass grafting surgery

Exclusion

  • Emergency or Redo surgery.
  • Baseline rhythm other than sinus rhythm
  • Any degree of heart block, bundle branch block or hemiblock
  • Known allergy to lidocaine.
  • Chronic kidney disease.
  • Hepatic impairment.
  • Severe psychiatric illness.

Key Trial Info

Start Date :

October 3 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT07205757

Start Date

October 3 2025

End Date

June 1 2026

Last Update

November 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fayoum University Hospital

Al Fayyum, Egypt